Robert Blouin is ready for the next day’s bypass surgery.
Display
Foundation - Friday 9 October, 2020
With support from the MHI Foundation’s donors, Dr. Jean-Claude Tardif was able to launch COLCOT-T2D, the second phase of the COLCOT study. The goal is to demonstrate that colchicine can also prevent cardiovascular diseases in diabetics.
Foundation - Thursday 8 October, 2020
Researchers at the Montreal Heart Institute launched a global study titled COLCOT (COLchicine Cardiovascular Outcomes Trial) in 2014. The goal was to determine whether colchicine, a widely available drug, could prevent the risk of heart attacks in patients who had already experienced this kind of event.
Foundation - Wednesday 7 October, 2020
Colchicine is an orally administered drug which has been garnering a lot of interest in the past few months. It has recently been the subject of scientific studies that have identified new indications. Let’s take a look at this readily available drug that represents a new hope for people with a variety of health conditions.
Foundation, in collaboration with Dr. Martin Juneau, cardiologist and Director of Prevention at the Institute - Monday 5 October, 2020
COVID-19 has had a significant impact on our lives these past months. Because it can be tricky to find out what is actually true among the vast amount of information available, Dr. Martin Juneau, cardiologist and Director of Prevention at the Montreal Heart Institute, answers your questions about the link between the novel coronavirus and heart disease.
Foundation, in collaboration with Dr. Serge Doucet, cardiologist and Director of Education at the Institute - Monday 21 September, 2020
Over the past few years, simulation-based education has become increasingly popular in the field of medicine. In fact, several articles have demonstrated its value and even suggested that it can reduce the number of errors made during real medical interventions. In this vein, the Institute’s Centre de formation et d’excellence en santé cardiovasculaire will soon offer new courses as part of its Simulation-based teaching program. Numerous healthcare professionals are already interested in the cardiac catheterization program.
Foundation, in collaboration with Dr. Judith Brouillette, psychiatrist - Monday 7 September, 2020
Did you know that stress has a direct effect on heart health? Though stress is vital for a healthy life, it can be harmful if it becomes chronic? Here are 5 tips to control stress and keep your heart healthy.
Foundation - Monday 24 August, 2020
The Colcorona genetic study is taking place at the Montreal Heart Institute’s Beaulieu-Saucier Pharmacogenomics Centre and is led by Dr. Marie-Pierre Dubé. This study invited participants who have already accepted to take part in the Colcorona study to voluntarily contribute their DNA. The study of their DNA will help researchers better understand why some patients develop a more severe form of COVID-19.
Foundation - Monday 27 July, 2020
Year after year, the Institute’s internationally renowned fellowship program welcomes over a dozen foreign medical specialists who wish to hone their skills in cardiovascular care. In addition to being an unparalleled personal experience for these health professionals, this complementary training program allows them to make a difference in the lives of the 68,000 patients who walk through the doors of the Institute each year.
Foundation - Friday 26 June, 2020
A healthy, active lifestyle is essential for good cardiovascular health. For sports lovers, it’s simple: a little dip in the pool over lunch hour, a spinning session after work or a good healthy walk in the evening, and you’re covered. But what if you don’t have the interest or ability to do sustained physical exercise like cycling, jogging or martial arts?
Foundation - Thursday 21 May, 2020
Through the acquisition of the da Vinci Xi surgical robot, the Montreal Heart Institute became the first medical establishment in Canada to devote this type of technology exclusively to cardiac surgery. An object of fascination and curiosity, the robot allows the Institute to work with next-level techniques and maintain its position as a leader in the field of precision medicine.
Robert Blouin is ready for the next day’s bypass surgery.